Malignant Abdominal Neoplasm — Trials

Malignant Abdominal Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

64 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 10
Recruiting: 6
Ph III recruiting: 1
Growth YoY: —
Industry share: 20%
Top sponsor: Varian, a Siemens Healthineers Company
Termination share: 16.1%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (5)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03453424	Analgesic Efficacy of Dexmedetomidine Added to Fentanyl in PCEA	completed	Phase 2 / Phase 3	90	South Egypt Cancer InstituteOTHER	1	Mar 23, 2020	clinicaltrials
NCT03460561	Peri-operative Rectus Sheath Block Versus TEA Abdominal Surgeries	completed	Phase 3	100	South Egypt Cancer InstituteOTHER	1	Mar 9, 2018	clinicaltrials